Research Grade Anti-Human CLDN6 & CD137 Bispecific Antibody (NBL-028)

Anti-Human CLDN6 & CD137 Bispecific Antibody (NBL-028) ( HX940046 ) is a research-grade recombinant antibody targeting CD137 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns.

Спецификация

Species reactivity	Human
Applications	ELISA, Functional assay, Research in vivo
Form	Liquid
Storage	-20℃
Product category‌	Biosimilar
Target	Claudin-6, CLDN6, Skullin, Tumor necrosis factor receptor superfamily member 9, CD137, 4-1BB ligand receptor, CDw137, TNFRSF9, T-cell antigen ILA, T-cell antigen 4-1BB homolog, ILA
Accession	P56747 & Q07011
Host species	Mammalian Cells

Информация для заказа

Область использования: Антитела Puda	Производство:	Puda Scientific
	Метод:	Иммуногистохимия
	Объем:	1mg
	Кат. номер:	PD-A26-518-100
Цена (с НДС 22%):	по запросу	В корзину
Наименование: Research Grade Anti-Human CLDN6 & CD137 Bispecific Antibody (NBL-028). Примечание: